All
Evolving Paradigm of TNBC Means One-Size-Fits All No Longer Applies to Treatment
November 1st 2022Over the past 20 years, chemotherapy has remained the primary treatment for triple-negative breast cancer. However, recent advancements have shown that a one-size-fits all treatment approach no longer works.